E
ELVN
Enliven Therapeutics Inc
50.80
-0.12-0.24%Closed17:42 07/08 EDT
OPEN/PREV CLOSE50.76/50.92
TODAY RANGE48.52-51.12
VOL1.12M
MARKET CAP3.63B
52 WEEK RANGE14.79-52.39
AVG VOL (3M)1.35M
% TURNOVER1.57%
TURNOVER0
P/E (TTM)-30.5417
% RANGE5.11%
EPS(TTM)-1.6633
P/E(FORWARD)-28.4594
P/B6.82
BVPS7.45
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.04B
SHARES OUTSTANDING71.42M
NEXT EARNINGS08/11-08/17
FREE FLOAT59.88M
LOT SIZE1
EX-DATE02/24/2023
News
Press Releases
Financial Reports
Profile
Simply Wall St·7h ago
Enliven Therapeutics (ELVN) Fell Out Of Russell Indexes, But Is The Valuation Already Rich?
Dow Jones·07/01 14:12
Enliven Therapeutics Is Maintained at Buy by Stifel
Dow Jones·07/01 14:12
Enliven Therapeutics Price Target Raised to $80.00/Share From $60.00 by Stifel
Benzinga·07/01 14:02
Stifel Maintains Buy on Enliven Therapeutics, Raises Price Target to $80
TipRanks·07/01 12:30
Enliven price target raised to $80 from $60 at Stifel
Dow Jones·06/29 15:41
Enliven Therapeutics Is Maintained at Buy by Jones Trading
Benzinga·06/29 15:34
Jones Trading Maintains Buy on Enliven Therapeutics, Raises Price Target to $70
Simply Wall St·06/26 00:26
22% Below Analyst Target, Is Enliven Therapeutics (ELVN) Fairly Valued Here
TipRanks·06/25 02:03
Major Investor Makes Bold Exit Move in Enliven Therapeutics Stock
Seeking Alpha·06/22 14:55
Enliven Therapeutics: Continuing The Pop Off; What Could Go Wrong?
TipRanks·06/18 02:02
Major Investor Makes Bold Move With Enliven Therapeutics Stake
Same Industry
Name/Symbol
Change%
Price